ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 38 filers reported holding ACER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | -99.9% | 1 | -99.9% | 0.00% | – |
Q2 2023 | $685 | -61.1% | 741 | -68.1% | 0.00% | – |
Q1 2023 | $1,761 | -67.9% | 2,322 | +6.1% | 0.00% | – |
Q4 2022 | $5,492 | +83.1% | 2,188 | +0.6% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 2,174 | -0.0% | 0.00% | – |
Q2 2022 | $3,000 | – | 2,175 | +27087.5% | 0.00% | – |
Q1 2022 | $0 | – | 8 | +700.0% | 0.00% | – |
Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q2 2020 | $13,000 | +160.0% | 3,857 | +49.1% | 0.00% | – |
Q1 2020 | $5,000 | -81.5% | 2,586 | -61.6% | 0.00% | – |
Q4 2019 | $27,000 | +28.6% | 6,737 | +3.9% | 0.00% | – |
Q3 2019 | $21,000 | +75.0% | 6,482 | +117.3% | 0.00% | – |
Q2 2019 | $12,000 | -91.2% | 2,983 | -47.0% | 0.00% | – |
Q1 2019 | $137,000 | +158.5% | 5,625 | +114.0% | 0.00% | – |
Q4 2018 | $53,000 | -45.9% | 2,629 | -18.0% | 0.00% | – |
Q3 2018 | $98,000 | – | 3,207 | +19943.8% | 0.00% | – |
Q2 2018 | $0 | – | 16 | +433.3% | 0.00% | – |
Q1 2018 | $0 | – | 3 | -40.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 5 | -87.2% | 0.00% | – |
Q3 2017 | $1,000 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 250,518 | $722,000 | 0.59% |
Nantahala Capital Management | 990,655 | $2,853,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 82,421 | $237,000 | 0.04% |
FEDERATED HERMES, INC. | 117,673 | $339,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 179 | $516,000 | 0.00% |
Horan Securities, Inc. | 24 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 200 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
NORTHERN TRUST CORP | 31,083 | $90,000 | 0.00% |